EVLO - Evelo Biosciences - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

EVLO is currently covered by 3 analysts with an average price target of $1.32. This is a potential upside of $1.27 (2540%) from yesterday's end of day stock price of $0.05.

Evelo Biosciences's activity chart (see below) currently has 15 price targets and 15 ratings on display. The stock rating distribution of EVLO is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.19% with an average time for these price targets to be met of 85.29 days.

Highest price target for EVLO is $2, Lowest price target is $2, average price target is $1.32.

Most recent stock forecast was given by VIKRAM PUROHIT from MORGAN STANLEY on 26-Jul-2023. First documented stock forecast 04-Jun-2018.

Currently out of the existing stock ratings of EVLO, 3 are a BUY (60%), 2 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$1.95 (3900.00%)

80

9 months 3 days ago

1/2 (50%)

$-5.88 (-74.62%)

83

Buy

10

$9.96 (24900.00%)

10

1 years 1 months 13 days ago

2/2 (100%)

$4.82 (93.05%)

79

Buy

5

$4.96 (12400.00%)

1 years 1 months 14 days ago

1/1 (100%)

$-0.98 (-16.39%)

4

Buy

280

1 years 2 months 28 days ago

1/3 (33.33%)

$120.6 (75.66%)

6

Buy

50

$49.95 (99900.00%)

12

1 years 5 months 13 days ago

3/4 (75%)

$4.2 (9.17%)

100

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EVLO (Evelo Biosciences) average time for price targets to be met?

On average it took 85.29 days on average for the stock forecasts to be realized with a an average price target met ratio 76.19

Which analyst has the current highest performing score on EVLO (Evelo Biosciences) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on EVLO (Evelo Biosciences) with a proven track record?

GARY NACHMAN

Which analyst has the most public recommendations on EVLO (Evelo Biosciences)?

Keay Nakae works at CHARDAN CAPITAL and has 7 price targets and 5 ratings on EVLO

Which analyst is the currently most bullish on EVLO (Evelo Biosciences)?

Matthew Harrison with highest potential upside - $259.95

Which analyst is the currently most reserved on EVLO (Evelo Biosciences)?

Chris Howerton with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?